Pfizer has partnered with the BMJ to help support improvements in clinical research and publication by providing free access to the BMJ’s Research to Publication e-learning course. Pfizer and the BMJ are inviting academic and healthcare organisations with an interest in conducting clinical research, epidemiological/public health research and/or health services research to apply for access to the Research to Publication course with the purpose of improving the conduct of, and publication rate for, clinical research. The BMJ’s Research to Publication course is a comprehensive six courses, 48 e-module programme.
Research to Publication is self-study programme designed to enable doctors and healthcare researchers to develop clinical research skills, write the best possible papers, and succeed in getting papers published. For more information on what the programme entails and how UK institutions may benefit from access, you can visit www.rtop.bmj.com.
There are two competitive grant programmes – a call for applications from institutions in the UK and another call for applications from institutions in Europe, Africa and the Middle East (with the exception of the UK). The direct link to the UK call information is here
Applications will be reviewed by a multidisciplinary panel comprised of independent experts in the fields of education and research and the panel will select the institutions to which access to Research to Publication is awarded based on pre-defined quality criteria.
The deadline for applications is 5pm on 30th April 2018 and following the expert panel’s review meeting, we anticipate notifying successful applicants no later than 30th June 2018